Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Sains dan Teknologi
Raden Verlisa Febriani
Undergraduate Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran
Agriculture, Biological Sciences & Forestry Chemistry Civil Engineering, Building, Construction & Architecture Physics Transportation

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
In Silico Study of Digitoxin from Foxglove (Digitalis purpurea L.) on Beta-1 Adrenergic Receptors in Heart Failure and Atrial Fibrillation Agung Adnan Pratama; Raden Verlisa Febriani; Cantik Batrisyia Ali; Riefka Berliana Khoir; Andi Salwa Karima; Dhania Novitasari
Jurnal Sains Dan Teknologi | E-ISSN : 3063-9980 Vol. 3 No. 1 (2026): Juli - September
Publisher : GLOBAL SCIENTS PUBLISHER

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Atrial fibrillation and heart failure are highly morbid and mortal cardiovascular diseases worldwide. Beta-1 adrenergic receptors are the mediators of cardiac function and the primary therapeutic targets in both diseases. Digitalis purpurea L., popularly known as foxglove or thimble flower is a medicinal herb used traditionally to cure heart disease and contains a cardiac glycoside alkaloid compound, digitoxin. This study aims to investigate in silico the potential interaction of digitoxin with beta-1 adrenergic receptors as a drug lead for heart failure and atrial fibrillation treatment. Bioactive compounds of Digitalis purpurea were systematically evaluated for their physicochemical properties according to Lipinski’s Rule of Five (RO5), pharmacokinetic profiles via ADMET prediction, pharmacophore features using LigandScout, and molecular interactions through molecular docking employing AutoDock 4.2.6. Results demonstrated that digitoxin has best oral bioavailability and intensively binds beta-1 adrenergic receptors with a Gibbs free energy of -9.24 kcal/mol, where hydrogen and hydrophobic interactions between digitoxin and receptor active site residues form. All of these show that digitoxin may be able to be developed as a heart failure and atrial fibrillation natural-based drug.
Co-Authors Agung Adnan Pratama Andi Salwa Karima Cantik Batrisyia Ali Dhania Novitasari Riefka Berliana Khoir